The augment of regulatory T cells undermines the efficacy of anti-PD-L1 treatment in cervical cancer

Xu, FY; Zhang, FY; Wang, Q; Xu, Y; Xu, SF; Zhang, CH; Wang, LH

Wang, LH (corresponding author), Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Dept Gynecol Oncol, Sch Med, 910 Hengshan Rd, Shanghai 200030, Peoples R China.

BMC IMMUNOLOGY, 2021; 22 (1):

Abstract

Background Immune checkpoint inhibitors have aroused great expectation of tumor eradication. However, the effect of anti-PD-L1 treatment for cervical ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索